Ortoma: Following the set path - Redeye

Redeye makes minor revisions based on the Q3 report. Ortoma continues to follow the outlined plan, and with the DePuy agreement, the upcoming 12 months are exciting. We slightly increase our fair value range and Base case to SEK14.5 per share. In connection with this report, we also changed the head analyst.

Länk till analysen i sin helhet: https://www.redeye.se/research/951623/ortoma-following-the-set-path?utm_source=finwire&utm_medium=RSS